Amphastar Pharmaceuticals (AMPH) CFO Peters gave up 4,972 shares at an average $27.28 to cover taxes or an exercise price
Insider transactions reported
William J Peters (CFO, EVP & Treasurer at Amphastar Pharmaceuticals Inc., AMPH) reported that they gave up 4,972 shares at an average $27.28 to cover taxes or an exercise price between Mar 15, 2025 and Mar 17, 2025. After these transactions the filing shows 125,258 shares held directly.
- Reporting person
- Peters William J
- Role
- CFO, EVP & TREASURER
| Date | Type | Security | Shares | Price | Value | Held after |
|---|---|---|---|---|---|---|
| Mar 15, 2025 | Shares withheld for taxes or exercise price (F) | Common Stock1 | -1,968 | $26.66 | $52.5K | 128,262 direct |
| Mar 17, 2025 | Shares withheld for taxes or exercise price (F) | Common Stock1 | -3,004 | $27.69 | $83.2K | 125,258 direct |
Holdings before and after
- Common Stock: 130,230 to 125,258 direct
Footnotes from the filing
- 1. The reported shares were withheld to satisfy the reporting person's tax liability in connection with the vesting of restricted stock units, or RSUs.
Transaction codes in this filing
- Shares withheld for taxes or exercise price:
- Code F marks shares handed back or withheld to pay taxes or an exercise price. No sale happens in the market.
FAQ
What did Peters report in this AMPH Form 4?
William J Peters (CFO, EVP & Treasurer at Amphastar Pharmaceuticals Inc., AMPH) reported that they gave up 4,972 shares at an average $27.28 to cover taxes or an exercise price between Mar 15, 2025 and Mar 17, 2025. After these transactions the filing shows 125,258 shares held directly.
How many AMPH shares does Peters hold after this filing?
The filing shows 125,258 shares held directly after the reported transactions. Form 4 reports only the positions it lists, so this may not be every holding.
What does transaction code F mean on an SEC Form 4?
Code F marks shares handed back or withheld to pay taxes or an exercise price. No sale happens in the market.
Historical context for AMPH
Earlier insider filings at AMPH
- Mar 12, 2025SENIOR EVP, PRODUCTION CENTER Zhou Rong was granted 24,692 units of Common Srock, increasing direct ownership by 21% to 140,686 units (SEC Form 4)
- Mar 12, 2025EVP CORP ADMIN CENTER Liawatidewi Yakob was granted 20,837 shares, increasing direct ownership by 29% to 93,671 units (SEC Form 4)
- Mar 12, 2025CFO, EVP & TREASURER Peters William J was granted 36,747 shares, increasing direct ownership by 39% to 130,230 units (SEC Form 4)
- Mar 12, 2025CEO & CHIEF SCIENTIFIC OFFICER Zhang Jack Y. was granted 165,222 shares, increasing direct ownership by 5% to 2,609,382 units (SEC Form 4)
- Mar 10, 2025SENIOR EVP, PRODUCTION CENTER Zhou Rong covered exercise/tax liability with 1,354 shares, decreasing direct ownership by 1% to 115,994 units (SEC Form 4)
Keep researching AMPH
- AMPH insider tradesEvery buy and sale reported by Amphastar Pharmaceuticals Inc. officers, directors and large holders.
- What is Form 4?The SEC filing that reports a change in an insider's holdings, such as a purchase, sale, option exercise or grant, generally within two business days.
- Form 4 explainedForm 4 is the SEC filing that discloses when officers, directors and 10% owners buy or sell company stock, due within 2 business days. Learn every key field and code.
- Insider trading trackerThe latest insider buys and sales across every stock.
- AMPH earnings historyPast Amphastar Pharmaceuticals Inc. earnings releases, newest first.
- AMPH financial statementsRevenue, profit, cash flow and balance sheet from Amphastar Pharmaceuticals Inc.'s SEC filings.
- Market cap
- 30-day
- Sector
- Health Care
- Industry
- Biotechnology: Pharmaceutical Preparations
- Listed since
- 2014
Follow AMPH and get a push notification the moment its next story breaks.